Document Detail


Polypharmacy with antidepressants in children and adolescents.
MedLine Citation:
PMID:  23190624     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
The aim of this study was to review current epidemiological data on the use of antidepressants in co-prescription with other psychotropic drugs in children and adolescents, as well as available efficacy and safety information. A Medline search from inception until February 2012 was performed to identify epidemiological and clinical studies, reviews and reports containing potentially relevant information on polypharmacy with antidepressants in young people. There has been an increase in polypharmacy in children and adolescents involving antidepressants in recent years. Antidepressants have become one of the drug classes most frequently prescribed in combination and are commonly co-prescribed with stimulants and antipsychotics. Most information regarding efficacy and safety of polypharmacy patterns was provided by case series and open-label studies. Efficacy studies gave some support for the use of a combination of antidepressants and antipsychotics in the management of refractory obsessive-compulsive disorder and some residual symptoms in major depressive disorder. Even less empirical support was found for a combination of stimulants and antidepressants in co-morbid attention deficit hyperactivity disorder and mood or anxiety disorders. Adverse events were similar to those found with individual medication groups, with severe adverse events mostly reported by individual case reports. The use of polypharmacy with antidepressants has become a regular practice in clinical settings. Although there is still little efficacy and safety information, preliminary evidence points to the potential clinical usefulness of some polypharmacy patterns. Further research on patients with co-morbidities or more severe conditions is needed, in order to improve knowledge of this issue.
Authors:
Covadonga M Díaz-Caneja; Ana Espliego; Mara Parellada; Celso Arango; Carmen Moreno
Related Documents :
12622824 - Association of mycothiol with protection of mycobacterium tuberculosis from toxic oxida...
10852894 - In vivo splicing and functional characterization of mycobacterium leprae reca.
20570524 - Crystallographic and docking studies of purine nucleoside phosphorylase from mycobacter...
11338484 - Sensitive differential detection of genetically related mycobacterial pathogens in arch...
19127654 - Autism profiles of males with fragile x syndrome.
23483924 - Tuberculosis incidence correlates with sunshine: an ecological 28-year time series study.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-11-29
Journal Detail:
Title:  The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP)     Volume:  -     ISSN:  1469-5111     ISO Abbreviation:  Int. J. Neuropsychopharmacol.     Publication Date:  2012 Nov 
Date Detail:
Created Date:  2012-11-29     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9815893     Medline TA:  Int J Neuropsychopharmacol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  1-20     Citation Subset:  -    
Affiliation:
Child and Adolescent Psychiatry Department, Hospital General Universitario Gregorio Marañón, Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The value of matrix metalloproteinase-9 and vascular endothelial growth factor receptor 1 pathway in...
Next Document:  Risser patient satisfaction scale: a validation study in Greek cancer patients.